h prevalence of Pneumocystis jirovecii colonization among patients with autoimmune inflamma-tory diseases and corticosteroid therapy / / Scand J Rheumatol. 2012. Vol. 41 (3). Р. 208-213.
33. Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality / / Arthritis Rheum. 1999. Vol. 42 (4). Р. 780-789.
34. Hugle B., Solomon M., Harvey E., James A., Wadhwa A., Amin R., Bell-Peter A., ??Benseler S. Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granu-lomatosis / / Arthritis Care Res (Hoboken). 2010. Vol. 62 (11). Р. 1661-1664.
35. Teichmann LL, Woenckhaus M., Vogel C., Salzberger B., Sch? Lmerich J., Fleck M. Fa-tal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis / / Rheumatology (Oxford). 2008. Vol. 47 (8). Р. 1256-1257.
36. Tsai M.J., Chou C.W., Lin F.C., Chang S.C. Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy / / Lupus. 2012. Vol. 21 (8). Р. 914-918.
37. Sepkowitz K.A. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome / / Clin Infect Dis. 2002. Vol. 34 (8). Р. 1098-1107.
38. Gerrard J.G. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults / / Med J Aust. 1995. Vol. 162 (5). Р. 233-235.
39. Stamp. LK., Hurst M. Is there a role for consensus guidelines for P. jiroveci pneumonia prophylaxis in immunosuppressed patients with rheumatic diseases?// J Rheumatol. 2010. Vol. 37 (4).
Р. 686-688.
40. Bengtsson C., Kapetanovic MC, K? Llberg H., Sverdrup B., Nordmark B., Klareskog L., Alfredsson L. EIRA Study Group. Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study / / Ann Rheum Dis. 2010. Vol. 69 (10).
Р. 1831-1833.
41. Van Assen S., Agmon-Levin N., Elkayam O., Cervera R., Doran MF, Dougados M., Em-ery P., Geborek P., Ioannidis JP, Jayne DR, Kallenberg CG, M? Ller-Ladner U., Shoenfeld Y., Stojanovich L., Valesini G., Wulffraat NM, Bijl M. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases / / Ann Rheum Dis. 2011. Vol. 70 (3). Р. 414-422.
42. Kavanaugh A. Infection prophylaxis in antirheumatic therapy: emphasis on vaccination / / Curr Opin Rheumatol. 2009. Vol. 21 (4). Р. 419-424.
Для підготовки даної роботи були використані матеріали з сайту рмж.рф
Дата додавання: 27.01.2014
